| Literature DB >> 33182342 |
Shuang Han1, Yuhui Zhao1, Zhichao Zhang1, Guobao Xu2,3.
Abstract
Metal nanoclusters (NCs), including Au, Ag, Cu, Pt, Ni and alloy NCs, have become more and more popular sensor probes with good solubility, biocompatibility, size-dependent luminescence and catalysis. The development of electrochemiluminescent (ECL) and chemiluminescent (CL) analytical methods based on various metal NCs have become research hotspots. To improve ECL and CL performances, many strategies are proposed, from metal core to ligand, from intermolecular electron transfer to intramolecular electron transfer. Combined with a variety of amplification technology, i.e., nanostructure-based enhancement and biological signal amplification, highly sensitive ECL and CL analytical methods are developed. We have summarized the research progresses since 2016. Also, we discuss the current challenges and perspectives on the development of this area.Entities:
Keywords: aggregation-induced emission; catalysts; chemiluminescence; electro- chemiluminescence; fluorescence; luminophore; nanoclusters; quenchers; sensors
Mesh:
Substances:
Year: 2020 PMID: 33182342 PMCID: PMC7664927 DOI: 10.3390/molecules25215208
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Schematic representation of the strategies for improving the ECL efficiency of metal NCs.
Figure 2Schematic Illustration of the proposed NIR ECL sensing strategy with Met/Au NCs as ECL tags. (A) Synthesis of Met-Au NCs-Ab2. (B) Immobilization of Met-Au NCs-Ab2 onto the GCE surface via the proposed sandwich immunoassay strategy. Reprinted from [53] with permission from ACS.
Figure 3Schematic diagram showing fabrication of the ECL aptasensor. (I) synthesis of the A3 bioconjugate (A3/Au25 NCs-Cu2O@CuNPs-DEDA) and the B3 bioconjugate (B3/Au25 NCs-TiO2 NSs), (II) working principle of the aptasensor for MUC1 and CEA simultaneous detection, and (III) a possible ECL mechanism of simultaneous cathodic and anodic ECL emissions of the Au25 NCs on an interface. Reprinted from [46] with permission from ACS.
Figure 4Schematic representation versatile ECL and electrochemical detection of thrombin based on silver nanoclusters in situ synthesized by multiple signal amplification strategy. (A) DNAzyme-assisted amplification, and (B) HCR process. Reprinted from [66] with permission from Elsevier.
Figure 5Schematic Illustration of the Nanocranes-Based Biosensor: (A) Target-Nucleotide Transduction-Amplification Strategy; (B) Programmable Modulation of the ECL Efficiency of Cu NCs; (C) Signal Comparison of miRNA-155 Detection (dx = Lateral Spacing of Cu NCs; ds = Particle Size of Cu NCs). Reprinted from [71] with permission from ACS.
Figure 6Schematic diagram of the “on–off” ECL biosensing platform for versatile detection of thrombin and miRNA-21 based on Ag(I) ion accelerated and Ag NC-quenched ECL combined with molecular machine-triggered chain reaction and MSN double amplification. (A) The ECL process of CdSe QDs + S2O82− system; (B) The ECL process of CdSe QDs + S2O82− system with Ag(I) ions as coreaction accelerators; (C) The ECL process of CdSe QDs + S2O82− system with Ag NCs as acceptors and CdSe QDs as donors. Reprinted from [76] with permission from RSC.
Methods to improve ECL efficiency of Au NCs, AgNCs and Cu NCs.
| Position | Methods | ECL System of Au NCs | Ref. |
|---|---|---|---|
| Metal core | Reduction of NCs | [ | |
| GSH stabilized Au NCs + K2S2O8 | |||
| Pre-oxidation of NCs | L-methionine stabilized Au NCs + TEA | [ | |
| Dithiothreitol stabilized Au NCs and BSA/Au NCs + TEA | |||
| Doping Strategy of NCs | Doping of Ag into BSA/Au NCs + TEA | [ | |
| Bimetallic NCs | GSH stabilized AuAg NCs + K2S2O8 | [ | |
| Au12Ag13 NCs + TPrA | [ | ||
| Ligand | New Ligand | L-methionine stabilized Au NCs + K2S2O8 | [ |
| L-methionine stabilized Au NCs + triethanolamine | [ | ||
| Double Ligand | Thioglycol/glutathione dual ligand-coated Au NCs + TEA | [ | |
| Rigid Host-Guest Assemblies | Mixed L-arginine (ARG) and 6-aza-2-thiothymine (ATT) protected Au NCs + TPrA | [ | |
| External environment | Novel coreactants | LA-stabilized Au NCs / EDTA | [ |
| LA-stabilized Au NCs / HEPES | [ | ||
| Coreaction accelerator | BSA/AuNCs + K2S2O8, highly-branched Cu2O as the coreaction accelerator | [ | |
| BSA/AuNCs + TEA, Cu2S snowflake as the coreaction accelerator | [ | ||
| BSA/AuNCs + K2S2O8, thiocholine produced in situ as the coreaction accelerator | [ | ||
| Intramolecular Electron Transfer: Binary or ternary nanostructure formed by luminophores, coreactants and coreaction accelerators via covalent attachment | Binary nanostructure formed by LA/Au NCs as the luminophore and DEDA as the coreactant | [ | |
| Binary nanostructure formed by TA/Au NCs as the luminophore and DPEA as the coreactant | [ | ||
| Ternary nanostructure formed by BSA/Au NCs as the luminophore, TAEA as the coreactant and Pd@CuO nanomaterial as the coreaction accelerator | [ | ||
| Binary nanostructure formed by BSA/Au NCs as the luminophore, TiO2 nanosheets as the coreaction accelerator with O2 as the coreactant. | [ | ||
| Ternary nanostructure of BSA/Au NCs- as the luminophore, Cu2O@Cu nanoparticles as the coreaction accelerator, and DEDA as the coreactant. | |||
| Aggregation-Induced ECL | ATT/Au NCs + TEA | [ | |
| ATP/Au NCs after Ca2+ induced aggregation + HEPES | [ | ||
| Nanostructure-based Enhancement | BSA/Au NCs + K2S2O8, nanoporous NiGd–Ni2O3–Gd2O3@Au nanoparticles as sensor platform | [ | |
| Synergistic Effect and ECL resonance energy transfer | Au NCs@ GQDs nanocomposite as the luminophore, GQDs as a donor, Au NCs as an acceptor | [ | |
| Biological Signal Amplification | Au NCs dual-labeled with hairpin DNA (H1 and H2) + K2S2O8, using HCR signal amplification. | [ | |
| Position | Methods | ECL system of Ag NCs | Ref. |
| Metal core | Design DNA structure to improve the stability and uniformity of Ag NCs | Triplex DNA templated Ag NCs + Na2S2O8, | [ |
| External environment | Biological signal amplification | DNA/Ag NCs + K2S2O8, DNAzyme-assisted target recycling and HCR multiple amplification strategy | [ |
| Coreaction accelerators | Ag NCs + K2S2O8, Fe3O4-CeO2 nanocomposites as coreaction accelerator | [ | |
| Surface plasmon-enhanced ECL | DNA templated Ag NCs as the luminophore and Au NPs as the localized surface plasmon resonance source | [ | |
| Metal core | Design DNA structure to improve the stability and less collision of Cu NCs | DNA nanocrane/Cu NCs + K2S2O8 | [ |
| Recombination | Nanocomposite DTT/Cu NCs / CNNSs + K2S2O8 | [ | |
| Doping the rich electronic rare earth element into Cu NCs | Eu3+ ion doped GSH stabilized Cu NCs | [ | |
| External environment | Coreaction accelerators and biological signal amplification | dsDNA/Cu NCs + K2S2O8, TiO2 as coreaction accelerator, exonuclease III-assisted amplification and HCR | [ |
Figure 7Sensitive detection of kanamycin by the CL sensing strategy based on the catalysis of DNA templated Au NCs. Reprinted from [84] with permission from RSC.
Recently reported ECL and CL biosensors using metal NCs.
| Detection Technique | Metal NCs or Probe | Target | Linear Range | LOD | Ref. |
|---|---|---|---|---|---|
| ECL | Graphene/Au NCs + K2S2O8 | H2O2 | 4–24 μM | 2 μM | [ |
| BSA/Au NCs + K2S2O8 | Dopamine | 2.5–7.5 μM | - | [ | |
| Graphene/multiwall carbon nanotube/Au NCs + K2S2O8 | Hydroquinone | 1.0–60 μM | 0.3 μM | [ | |
| Resorcinol | 3.0–70 μM | 1.0 μM | |||
| 5.0–60 μM | 1.7 μM | ||||
| 4–70 μM | 1.3 μM | ||||
| 2-Bromophenol | 5–70 μM | 1.7 μM | |||
| DNA/Ag NCs + K2S2O8 | MicroRNA-21 | 100 aM–100 pM | 22 aM | [ | |
| BSA/Cu NCs + hydrazine | Dopamine | 1.0 × 10−12–1.0 × 10−8 M | 3.5 × 10−13 M | [ | |
| Met/Au NCs + K2S2O8 | Dopamine | 0.1–4 μM | 32 nM | [ | |
| BSA/AuAg NCs + triethylamine | Hg2+ | 10 nM–5 μM | 5 nM | [ | |
| GSH/AuAg NCs + TEA, Ag NPs as a coreaction accelerator | GSH | 5–200 μM | 0.90 μM | [ | |
| GSH/AuAg NCs + K2S2O8 | Dopamine | 10 nM–1 mM | 2.3 nM | [ | |
| Adenosine mono-/di-/triphosphate/Au NCs + TEA | Calmodulin | 0.3–50 μg mL−1 | 0.1 μg mL−1 | [ | |
| BSA/Au NCs + DEDA | CEA | 1 pg mL−1–1 ng mL−1 | 0.43 pg mL−1 | [ | |
| MUC1 | 10 fg mL−1–1 ng mL−1 | 5.8 fg mL−1 | |||
| BSA/Au NCs + H2O2 | 5-Methylcytosine-DNA | 0.01–50 nM | 3.46 pM | [ | |
| Ten-eleven translocation 1 protein | 1–10 μg mL−1 | 0.37 μg mL−1 | |||
| T4 β-glucosyltransferase | 0.5–50 unit mL−1 | 0.176 unit mL−1 | |||
| BSA/Au NCs + TEA | Concanavalin A | 0.004–90 ng mL−1 | 0.001 ng mL−1 | [ | |
| NAC/Au NCs + K2S2O8 | GSH | 1.0 × 10−9–1.0 × 10−5 M and 1.0 × 10−5–1.0 × 10−1 M | 3.2 × 10−10 M | [ | |
| Met/Au NCs + triethanolamine | α-Fetoprotein | 3 fg mL−1–0.1 ng mL−1 | 1 fg mL−1 | [ | |
| BSA/Au NCs + TAEA | CEA | 100 fg mL−1–100 ng mL−1 | 16 fg mL−1 | [ | |
| BSA/Au NCs + K2S2O8 | Procalcitonin | 10 fg mL−1–100 ng mL−1 | 2.90 fg mL−1 | [ | |
| BSA/Au NCs + TEA | Procalcitonin | 10 fg mL−1–100 ng mL−1 | 2.36 fg mL−1 | [ | |
| BSA/Au NCs + K2S2O8 | ATCI | 0.50 nM–0.47 mM | 0.17 nM | [ | |
| TA/Au NCs +DPEA | Mucin 1 | 1 fg mL−1–1 ng mL−1 | 0.54 fg mL−1 | [ | |
| BSA/Au NCs + K2S2O8 | CEA | 10−4–5 ng mL−1 | 0.03 pg mL−1 | [ | |
| BSA/Au NCs/GQDs + TEA | Pentoxifylline | 7.0 × 10−7–1.2 × 10−4 M | 9.0 × 10−8 M | [ | |
| GSH/Au NCs + K2S2O8 | Cardiac troponin I | 5 fg mL−1–50 ng mL−1 | 1.01 fg mL−1 | [ | |
| Triplex DNA/Ag NCs | Cys | 0.5–50 μM | 0.5 μM | [ | |
| DNA/Ag NCs + K2S2O8 | Thrombin | 10.0 fM–10.0 nM | 4.5 fM | [ | |
| Ag NCs + K2S2O8 | CCND1 | 50 fg mL−1–50 ng mL−1 | 28 fg mL−1 | [ | |
| DNA/AgNCs + K2S2O8 | MicroRNA-21 | 1 aM–104 fM | 0.96 aM | [ | |
| DNA/Cu NCs + K2S2O8 | MicroRNA-21 | 100 aM–100 pM | 19.05 aM | [ | |
| DNA/Cu NCs + K2S2O8 | MicroRNA-155 | 100 aM–100 pM | 36 aM | [ | |
| DTT/Cu NCs + K2S2O8 | Hg2+ | 0.5–10 nM | 0.01 nM | [ | |
| Eu3+-Cu NCs | Dopamine | 1.0 × 10−11–5.0 × 10−4 M | 1.0 × 10−11 M | [ | |
| Pt NCs/graphene + TEA | Cu2+ | 1.0 × 10−4–2.0 × 10−1 mg L−1 | 1.0 × 10−4 mg L−1 | [ | |
| Ni NCs + TPrA | Creatinine | 5 nM–1 mM | 0.5 nM | [ | |
| DNA/Ag NCs + K2S2O8 | Thrombin | 0.001–1000 pM | 0.165 fM | [ | |
| MicroRNA-21 | 0–103 pM, 10−5–103 pM | 4.97 aM | |||
| GSH/Au NCs + K2S2O8 | Cardiac troponin I | 50 fg mL−1–50 ng mL− | 9.73 fg mL−1 | [ | |
| g-C3N4 as a ECL emitter, BSA/Au NCs as catalyst | Protein kinase A | 0.02–20 U mL−1 | 0.005 U mL−1 | [ | |
| Pt NCs both as the acceptor and donor | MicroRNA-141 | 10 aM–100 nM | 3.3 aM | [ | |
| CL | Penicillamine/AuCu NCs | H2O2 | 0.2–2000 nM | 0.13 nM | [ |
| Glucose | 0.1–400 μM | 30 nM | |||
| Xanthine | 0.1–200 μM | 38 nM | |||
| KMnO4 + rhodamine B enhanced by BSA/Au NCs and GQDs | Cimetidine | 0.8–200 ng mL−1 | 0.3 ng mL−1 | [ | |
| KMnO4 + rhodamine B enhanced by BSA/Ag NCs and GQDs | Rabeprazole | 4–133 ng mL−1 | 1.1 ng mL−1 | [ | |
| Cysteine/Cu NCs + cerium | Trihexyphenidyl hydrochloride | 0.1–10.0 μM | 49.0 nM | [ | |
| BSA/Au NCs + KMnO4 | H2O2 | 1.0 ×10−6–1.0 × 10−4M | 5.0×10−7 M | [ | |
| BSA/AuNCs as an energy acceptor and bis(2,4,6-tri-chlorophenyl)- oxalate–hydrogen peroxide as an energy donor | Trypsin | 0.01–50.0 μg mL−1 | 9 ng mL−1 | [ | |
| hPEI-AgNCs + H2O2 | Tea polyphenols | 2.52–76.2 μM | 2.52 μM | [ | |
| H2O2-HCO3− system, CdSe QDs as catalyst, BSA/Au NCs as quencher | Cyanide | 2–225 nM | 0.46 nM | [ | |
| Au NCs as catalyst | Nitrite | 5 μM–0.1 mM | 4.7 μM | [ | |
| Au NCs as catalyst | Catechol | 0.1–10 μM | 0.062 μM | [ | |
| Ag NCs as catalyst | H2O2 | 0.14–100 μM | 0.016 μM | [ | |
| Uric acid | 2–100 μM | 0.75 μM | |||
| Au NCs as catalyst | Kanamycin | 0.2–4.4 nM | 0.035 nM | [ | |
| Cu NCs as catalyst | Cholesterol | 0.05–10 mM | 1.5 μM | [ | |
| Cu NCs as catalyst | Phenylalanine | 1.0 × 10−6–2.7 × 10−5 M | 8.4 × 10−7 M | [ | |
| Tryptophan | 1.0 × 10−7–3.0 × 10−5 M | 7.5 × 10−8 M | |||
| Cu NCs as catalyst | Tryptophan | 2.0 × 10−7–10−4 M | 6 × 10−8 M | [ | |
| Cu NCs as catalyst | Nitrite | 1.0–80.0 μM | 0.0954 μM | [ | |
| Folic acid | 0.1–10.0 μM | 3.0 μM | |||
| Cu NCs@CuMOF as catalyst | Tramadol | 0.0030–2.5 μM | 0.80 nM | [ | |
| BSA/ZnCu NCs as catalyst | H2O2 | 5.0 × 10−9–1.0 × 10−6 M | 3.0 × 10−10 M | [ | |
| Hemoglobin/Au NCs as catalyst | Dopamine | 0.3–9.0 nM | 0.1 nM | [ | |
| Au NCs as catalyst | Bisphenol A | 2.0 × 10−7–1.0 × 10−5 M | 1.0 × 10−6 M | [ |